Fondo Bibliografico Internacional Marzo 2005
Hepatitis B.
Antibody levels and protection after hepatitis B vaccination:
results of a 15-year follow-up. McMahon BJ, Bruden DL, Petersen KM, et al.
Annals of Internal Medicine 2005;142:333-41.
Eficacia clínica a largo plazo, 15 años,
de la vacunación para el virus de la hepatitis B.
Long-term protection of hepatitis B vaccine: lessons from Alaskan
experience after 15 years. Chen DS. Annals of Internal Medicine 2005;142:384-5.
Editorial.
New insight on hepatitis B virus persistence from the study
of intrahepatic viral cccDNA. Zoulim F. Journal of Hepatology 2005;42:302-8.
Revisión.
Identification of Chronic Hepatitis B Patients without Significant
Liver Fibrosis by a Simple Noninvasive Predictive Model. Hui AY, Chan HL,
Wong VW, et al. American Journal of Gastroenterology 2005;100:616-23.
Nuevo índice para predecir la ausencia de
fibrosis en los pacientes con hepatitis crónica B.
Therapies for hepatitis B: where to from here? Locarnini S.
Gastroenterology 2005;128:789-92.
Editorial
